Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | ERN1 | O75460 | 5/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.31 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15514624 | 0.86 | TDP1 (0.45) | TDP1HSD17B10MEN1KMT2ALMNA | |
| SCHEMBL20088344 | 0.86 | TDP1 (0.45) | TDP1HSD17B10MEN1KMT2ALMNA | |
| SCHEMBL6904097 | 0.86 | TDP1 (0.45) | TDP1HSD17B10MEN1KMT2ALMNA | |
| SCHEMBL30207774 | 0.86 | TDP1 (0.45) | TDP1HSD17B10MEN1KMT2ALMNA | |
| SCHEMBL7762075 | 0.86 | TDP1 (0.45) | TDP1HSD17B10MEN1KMT2ALMNA | |
| SCHEMBL23049649 | 0.82 | ALDH1A1 (0.40) | TDP1MEN1KMT2ALMNATHRB | |
| SCHEMBL2956306 | 0.82 | TDP1 (0.38) | TDP1MEN1KMT2ALMNATHRB | |
| SCHEMBL13743748 | 0.82 | TDP1 (0.38) | TDP1HSD17B10MEN1KMT2ALMNA | |
| SCHEMBL17842808 | 0.82 | ALDH1A1 (0.40) | TDP1HSD17B10MEN1KMT2ALMNA | |
| SCHEMBL29955049 | 0.82 | ERN1 (0.48) | TDP1MEN1KMT2AERN1TRIM24 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1915331-B1 | PRODUCTION PROCESS OF NUCLEUS-HALOGENATED METHYLBENZYL ALCOHOL | SHOWA DENKO KK (JP) | 2013-07-10 | — | — | EP | disclosed |
| US-7939695-B2 | Production process of nucleus-halogenated methylbenzyl alcohol | SHOWA DENKO K.K. (JP) | 2011-05-10 | — | — | US | disclosed |
| CN-101193843-B | Production process of nucleus-halogenated methylbenzyl alcohol | SHOWA DENKO KK | 2011-05-04 | — | — | CN | disclosed |
| US-20100145106-A1 | PRODUCTION PROCESS OF NUCLEUS-HALOGENATED METHYLBENZYL ALCOHOL | SHOWA DENKO K.K. (JP) | 2010-06-10 | — | — | US | disclosed |
| CN-101193843-A | Production process of nucleus-halogenated methylbenzyl alcohol | SHOWA DENKO KK (JP) | 2008-06-04 | — | — | CN | disclosed |
| EP-1915331-A2 | PRODUCTION PROCESS OF NUCLEUS-HALOGENATED METHYLBENZYL ALCOHOL | Showa Denko K.K. (JP) | 2008-04-30 | — | — | EP | disclosed |
| WO-2006137348-A2 | PRODUCTION PROCESS OF NUCLEUS-HALOGENATED METHYLBENZYL ALCOHOL | SHOWA DENKO K.K. (JP) | 2006-12-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100145106-A1 | PRODUCTION PROCESS OF NUCLEUS-HALOGENATED METHYLBENZYL ALCOHOL | NPM1, MED1, KPNA2 | TDP1 3007/4885HSD17B10 674/4885MEN1 110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.